ABD'li biyoteknoloji şirketlerinin %79'u Çin şirketleri ile çalışıyor
- YazarFinansgundem
- •
İsim | Son | Fark % | Hac. | Zaman | Fiyat | |
---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology | 137,51 | +0,60% | 632,52K | 137,51+0,60% | 20/05 | |
IBBQ Invesco Nasdaq Biotechnology | 22,37 | +0,73% | 11,76K | 22,37+0,73% | 20/05 |
İsim | Son | Taban | Yüksek | Düşük | Fark % | Hac. | Zaman | Fiyat | |
---|---|---|---|---|---|---|---|---|---|
NVAX Novavax Inc | 14,79 | 13,01 | 14,80 | 12,68 | +13,68% | 14,03M | 14,79+13,68% | 20/05 | |
ERAS Erasca Inc | 2,24 | 1,97 | 2,295 | 1,87 | +13,71% | 12,27M | 2,24+13,71% | 20/05 | |
VTRS Viatris Inc | 11,07 | 10,98 | 11,21 | 10,98 | +0,82% | 11,3M | 11,07+0,82% | 20/05 | |
PACB Pacific Biosciences of California | 1,92 | 2,02 | 2,069 | 1,92 | -4,95% | 8,1M | 1,92-4,95% | 20/05 | |
CRBU Caribou Biosciences Inc | 3,13 | 3,39 | 3,45 | 3,02 | -7,67% | 7,57M | 3,13-7,67% | 20/05 |
İsim | Fiyat |
---|---|
DYN Dyne | 35,38+7,70+27,82% |
PTCT PTC Therapeutics | 40,12+7,03+21,23% |
ERAS Erasca | 2,24+0,270+13,71% |
NVAX Novavax | 14,79+1,780+13,68% |
HUMA Humacyte | 7,06+0,730+11,53% |
İsim | Fiyat |
---|---|
AUTL Autolus Therapeutics | 4,02-0,370-8,43% |
IBRX Immunitybio Inc | 7,04-0,61-7,97% |
REPL Replimune | 5,94-0,50-7,76% |
CRBU Caribou Biosciences | 3,13-0,260-7,67% |
SVRA Savara | 4,17-0,3100-6,92% |